Veterinary Medicines

Anthelmin 230 mg/20 mg film-coated tablets for cats

Authorised
  • Praziquantel
  • Pyrantel embonate
Download as PDF

Product identification

Medicine name:
Anthelmin 230 mg/20 mg film-coated tablets for cats
Anthelmin vet 230 mg / 20 mg tabletti, kalvopäällysteinen
Active substance:
  • Praziquantel
  • Pyrantel embonate
Target species:
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Praziquantel
    20.00
    milligram(s)
    /
    1.00
    Tablet
  • Pyrantel embonate
    230.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Film-coated tablet
Withdrawal period by route of administration:
  • Oral use
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AA51
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription except for some pack sizes
Authorisation status:
  • Valid
Authorised in:
  • Finland
Package description:
  • (ID7) 100 Film-coated tablet: unspecified outer container with 10 Blister (Orientated PolyAmide; Aluminium; PolyVinyl Chloride) each with 10 Film-coated tablet, closed with Foil (Aluminium)
  • (ID6) 50 Film-coated tablet: unspecified outer container with 5 Blister (Orientated PolyAmide; Aluminium; PolyVinyl Chloride) each with 10 Film-coated tablet, closed with Foil (Aluminium)
  • (ID5) 30 Film-coated tablet: unspecified outer container with 3 Blister (Orientated PolyAmide; Aluminium; PolyVinyl Chloride) each with 10 Film-coated tablet, closed with Foil (Aluminium)
  • (ID4) 10 Film-coated tablet: unspecified outer container with 1 Blister (Orientated PolyAmide; Aluminium; PolyVinyl Chloride) with 10 Film-coated tablet, closed with Foil (Aluminium)
  • (ID2) 4 Film-coated tablet: unspecified outer container with 2 Blister (Orientated PolyAmide; Aluminium; PolyVinyl Chloride) each with 2 Film-coated tablet, closed with Foil (Aluminium)
  • (ID1) 2 Film-coated tablet: unspecified outer container with 1 Blister (Orientated PolyAmide; Aluminium; PolyVinyl Chloride) with 2 Film-coated tablet, closed with Foil (Aluminium)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • KRKA tovarna zdravil d.d. Novo mesto
  • TAD Pharma GmbH
  • Krka-Farma d.o.o.
  • Krka-Farma d.o.o.
Responsible authority:
  • Finnish Medicines Agency
Authorisation number:
  • 33767
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0160/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Czechia
  • Estonia
  • Finland
  • France
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 14/02/2022
Download

Combined File of all Documents

English (PDF)
Published on: 14/06/2024
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Finnish (PDF)
Published on: 13/06/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."